Related content

Calcitriol does not prevent bone loss in patients with asthma receiving corticosteroid therapy: a double-blind placebo-controlled trial

By McDonald C.   Zebaze R.   Seeman E.  

Osteoporosis International, Vol. 17, Iss. 10, 2006-10 ,pp. : 1546-1551

Springer Publishing Company

Access to resources Recommend Favorite

Progression of vascular calcifications is associated with greater bone loss and increased bone fractures

By Naves M.   Rodríguez-García M.   Díaz-López J.   Gómez-Alonso C.   Cannata-Andía J.  

Osteoporosis International, Vol. 19, Iss. 8, 2008-08 ,pp. : 1161-1166

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate

By Richy Florent   Ethgen Olivier   Bruyere Olivier   Reginster Jean-Yves  

Osteoporosis International, Vol. 15, Iss. 4, 2004-04 ,pp. : 301-310

Springer Publishing Company

Access to resources Recommend Favorite

Systematic review and network meta‐analysis on the relative efficacy of osteoporotic medications: men with prostate cancer on continuous androgen‐deprivation therapy to reduce risk of fragility fractures

By  

BJU INTERNATIONAL, Vol. 121, Iss. 1, 2018-01 ,pp. : 17-28

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bone loss and the risk of non-vertebral fractures in women and men: the Tromsø study

By Ahmed L.   Emaus N.   Berntsen G.   Bjørnerem Å.   Fønnebø V.   Jørgensen L.   Schirmer H.   Størmer J.   Joakimsen R.  

Osteoporosis International, Vol. 21, Iss. 9, 2010-09 ,pp. : 1503-1511

Springer Publishing Company

Access to resources Recommend Favorite